Status: Closed
Activation Date: 2002JUN15
Closing Date: 2005APR15
Phase: III
Description: This Protocol is a Laboratory Companion for Southwest Oncology Group Coordinated Trials for Lung Cancer
Eligibility: Only patients previously registered to Southwest Oncology Group lung cancer treatment protocols will be registered to this study.
Objective: To establish a central lung cancer specimen repository to serve as a resource for current and future scientific studies. To utilize the Southwest Oncology Group clinical data base to perform clinicopathologic correlation with the results of those studies. To test new hypotheses as they emerge.
Participation: Open to member centres
Primary Publication Show
Other Publications Show
Inventory
Hide Tissue Samples
| Disease Site | Trial Code | Patients Accrued | Patients - Blocks | Patients - Slides | Patients - Blocks and/or Slides |
| LUNG | BR15C | 47 | 3 | 3 | 6 |
(Core size is 0.6 mm)
Hide
Fluid Samples| Disease Site | Trial Code | Patients Accrued | TMA Blocks | Patients on TMA Blocks |
| LUNG | BR15C | 47 | 0 | 0 |
| Disease Site | Trial Code | Patients Accrued | Patients - Whole Blood | Patients - Cellular Component of Blood | Patients - DNA extracted from Blood | Patients - RNA extracted from Blood | Patients - Plasma | Patients - Serum | Patients - Urine | Patients - Buccal |
| LUNG | BR15C | 47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |